Jidekangmin

China
Shimenjie, Jiangxi, China

Company profile

Jidekangmin company profile

Jidekangmin focuses on developing γδ-T cell-based immunotherapy products used particularly in cancer treatment.

Business identity

Operating status
Active
Company type
For Profit
Founded
2018-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Last funding
Series B / 2025-12-29
Last equity funding
Series B
Investors
1
Lead investors
1

Founders and investors

Lead investors

Health Industry Investment Fund

Investors

Health Industry Investment Fund